ReviewCancers2022

Treatment-Related Adverse Events of Combination EGFR Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Daisy Wai-Ka Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.